Recent Updates
Recently added Catalysts

Thalamic deep brain stimulation

Phase 2

Tourette Syndrome | Unknown | Neurology |Medtronic plc.|Trials Updated: May 12, 2022

Thalamic deep brain stimulation development status

Highest phase Phase 2
Registered trials 1 across 1 sponsor since Apr 2006

Success Probability

Subscribe to view

Market & Valuation

Subscribe to view

Trial Design

RandomizedDouble-BlindUNCONTROLLED
Total Trials1
Total Enrollment5

FDA Designations

No designations recorded

Thalamic deep brain stimulation clinical trials

Thalamic deep brain stimulation · 1 trial · 1 indication

Phase 2 1
NCT00311909Thalamic Deep Brain Stimulation for Tourette SyndromeTourette Syndrome
COMPLETED5 Analytics
PHASE2COMPLETED
Thalamic Deep Brain Stimulation for Tourette Syndrome
Tourette Syndrome
NCT003119095
Unlock trial analytics

Study Endpoints

Primary Endpoints

modified Rush Video Rating Scale (mRVRS)

Secondary Endpoints

tic counts (on video recording)
Yale Global Tourette Severity Scale (YGTSS)
Tourette Syndrome Symptom List (TSSL)
Unlock Study Endpoints

Study Design & Arms

AllocationRANDOMIZED
MaskingDOUBLE
ModelCROSSOVER
PurposeTREATMENT

Interventions

NameTypeDescription
Thalamic deep brain stimulationDEVICE -
Unlock Study Design Details

Eligibility Criteria

Age Range18 Years to N/A
SexALL
Healthy VolunteersNo
Study Sites1

Inclusion Criteria: * age 18 or older * Diagnosis of Tourette Syndrome by DSM-IV * Tic frequency at least one per minute at screening * prior failure of at least two dopamine receptor or presynaptic blockers * negative impact on quality of life Exclusion Criteria: * significant structural brain l...

Countries:United States
Unlock Eligibility Criteria

Explore more on BiopharmaWatch

Medtronic plc. (MDT)Pipeline, catalysts, financials, insiders and newsBiotech disease mapWho is developing what in each indication, and how crowded it isFDA calendarUpcoming PDUFA dates, AdComs and approval oddsPDUFA calendarEvery scheduled FDA decision date, month by monthHistorical FDA calendarPast decisions and how the stock moved on eachCatalyst SyncUpcoming readouts and decisions, screened by runway and phaseBiotech stock screenerFilter by clinical phase, cash runway and market capDrugs A to ZEvery drug page starting with TCompanies A to ZEvery biotech and pharma company we track